Pfizer to deliver 13 million doses of COVID-19 vaccine a week to the United States by mid-March, says executive

(Reuters) – Pfizer Inc. expects to deliver more than 13 million doses of COVID-19 vaccine a week to the United States by mid-March, more than doubling its deliveries in early February, an executive said. top of Pfizer, in statements prepared ahead of a Tuesday hearing of Congress.

Pfizer has delivered approximately 40 million doses to locations in the United States to date and is on track to deliver 120 million doses from its two-dose regimen by the end of March, said John Young, Pfizer’s business director. .

He added that Pfizer is also ready to deliver a total of 300 million photos to the United States by the end of July and raised global production expectations for 2021 to at least 2 billion doses.

In his own prepared remarks, Moderna Inc. President Stephen Hoge said the drug maker plans to deliver 100 million doses of its two-dose dose by the end of March and 300 million by the end of July.

Johnson & Johnson believes it will be able to ship at least 20 million doses of its single dose to the United States by the end of March, after receiving US regulatory clearance, said Richard Nettles, vice president of medical affairs. It expects to deliver 100 million doses by mid-2021, he said.

Drug maker’s remarks put the United States on track to receive 240 million doses by the end of March, enough to inoculate 130 million Americans and 700 million doses by mid-year, more than enough to dose the entire US population.

The comments were prepared ahead of a US congressional hearing on the availability of the vaccine, which will be held on Tuesday by the Chamber of Energy and Commerce Committee.